CNMD - CONMED Corporation
| Previous Close | 103.93 |
| Open | 104.24 |
| Bid | 105.18 x 900 |
| Ask | 105.41 x 1200 |
| Day's Range | 104.24 - 105.55 |
| 52 Week Range | 73.42 - 116.81 |
| Volume | 208,336 |
| Avg. Volume | 268,068 |
| Market Cap | 3.003B |
| Beta (5Y Monthly) | 0.53 |
| PE Ratio (TTM) | 108.68 |
| EPS (TTM) | 0.97 |
| Earnings Date | Apr 21, 2020 - Apr 26, 2020 |
| Forward Dividend & Yield | 0.80 (0.76%) |
| Ex-Dividend Date | Dec 11, 2019 |
| 1y Target Est | 124.00 |
- Business Wire
CONMED Corporation to Present at the SVB Leerink Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:30 a.m. ET on Wednesday, February 26, 2020 in New York, NY.
- Zacks
XRAY or CNMD: Which Is the Better Value Stock Right Now?
XRAY vs. CNMD: Which Stock Is the Better Value Option?
- Zacks
CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4
CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.
- Thomson Reuters StreetEvents
Edited Transcript of CNMD earnings conference call or presentation 29-Jan-20 9:30pm GMT
Q4 2019 Conmed Corp Earnings Call
- Simply Wall St.
CONMED Corporation’s (NASDAQ:CNMD) Investment Returns Are Lagging Its Industry
Today we'll evaluate CONMED Corporation (NASDAQ:CNMD) to determine whether it could have potential as an investment...
- Zacks
Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates
Conmed (CNMD) delivered earnings and revenue surprises of 1.12% and 0.01%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange
CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market.
- Business Wire
CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019.
- Zacks
Medical Products' Earnings Due on Jan 29: ALGN, HOLX & More
A series of product launches despite the ongoing regulatory hurdles is likely to favor revenues in the medical products space this earnings season.
- Zacks
Conmed (CNMD) Earnings Expected to Grow: Should You Buy?
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire
CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
- Investor's Business Daily
Stocks To Watch Ahead Of Earnings: ConMed
With earnings on tap for Jan. 20, ConMed is currently approximately 4% below a 116.91 buy point. The pattern is a second-stage flat base. Keep in mind that jumping into a stock right as it gets ready to report means you likely won't have enough time to build a profit cushion before the release.
- Business Wire
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA.
- Zacks
Here's Why You Should Invest in Patterson Companies Stock Now
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts.
- Zacks
Here's Why You Should Retain Pacific Biosciences Stock Now
Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, stiff competition remains a woe.
- Zacks
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.
- Zacks
HMS Holdings Acquires Nebraska-Based Intrado's Accent Unit
The latest deal is likely to boost HMS Holdings' (HMSY) Payment Integrity solutions business.
- Zacks
Here's Why You Should Hold on to Masimo (MASI) Stock Now
Masimo (MASI) raises revenue and earnings guidance for 2019.
- Zacks
PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?
PDCO vs. CNMD: Which Stock Is the Better Value Option?
- Zacks
6 MedTech Stocks That are Set to Beat the Market in 2020
Banking on the three key trends, we zero in on six MedTech stocks that are likely to deliver stellar performance in 2020.
- Zacks
Masimo (MASI) Expands Partnership with Texas-Based Drager
Masimo (MASI) sees a slew of developments in recent times.
- Zacks
Hill-Rom (HRC) Rides on International Growth, New Launches
Hill-Rom (HRC) launches RetinaVue 700 Imager, EarlySense and WatchCare in 2019.
- Zacks
LHC Group Expands Partnership With Ochsner Health System
LHC Group (LHCG) sees major expansion in partnerships of late.
- Simply Wall St.
Should You Be Concerned About CONMED Corporation's (NASDAQ:CNMD) ROE?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Zacks
Here's Why You Should Add DexCom (DXCM) to Your Portfolio
DexCom (DXCM) raises its 2019 revenue and EPS guidance.
